Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma

PHASE3RecruitingINTERVENTIONAL
Enrollment

346

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG

Cisplatin

cisplatin is to give from the first Day of radiation therapy D1,D22 Q3W for 2 cycles Radiation: IMRT IMRT is to give 60Gy in 27 fraction

RADIATION

IMRT

Radiation: IMRT IMRT is to give 60Gy in 27 fraction

Trial Locations (1)

510060

RECRUITING

WangHanYu, Guangzhou

All Listed Sponsors
collaborator

JiangXi Province Tumor Hospital

UNKNOWN

collaborator

Fujian Province Tumor Hospital

OTHER

collaborator

SiChuan Province Tumor Hospital

UNKNOWN

collaborator

Hunan Province Tumor Hospital

OTHER

collaborator

YuNan Province Tumor Hospital

UNKNOWN

collaborator

GuiZhou Province Tumor Hospital

UNKNOWN

collaborator

Hainan Cancer Hospital

OTHER

collaborator

Tongji Hospital

OTHER

collaborator

Second Affiliated Hospital of Nanchang University

OTHER

collaborator

Wuhan University

OTHER

collaborator

First Hospital of FoShan City

UNKNOWN

lead

Sun Yat-sen University

OTHER